INNOCOLL ANNOUNCES LAUNCH OF A NEW VERSION OF ITS COLLARX GENTAMICIN SURGICAL IMPLANT

Innocoll, Inc. announced its sales and marketing subsidiary, Innocoll Pharmaceuticals Ltd., has launched a new version of its CollaRx Gentamicin surgical implant that is specially designed for maximum convenience and ease of use in cardiac surgery. Finanzen Net (http://finanzen.net/news/news_detail.asp?NewsNr=392419)